Kritika Nayak

495 total citations
8 papers, 357 citations indexed

About

Kritika Nayak is a scholar working on Pharmaceutical Science, Public Health, Environmental and Occupational Health and Dermatology. According to data from OpenAlex, Kritika Nayak has authored 8 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 5 papers in Public Health, Environmental and Occupational Health and 1 paper in Dermatology. Recurrent topics in Kritika Nayak's work include Advanced Drug Delivery Systems (7 papers), Advancements in Transdermal Drug Delivery (5 papers) and Ocular Surface and Contact Lens (5 papers). Kritika Nayak is often cited by papers focused on Advanced Drug Delivery Systems (7 papers), Advancements in Transdermal Drug Delivery (5 papers) and Ocular Surface and Contact Lens (5 papers). Kritika Nayak collaborates with scholars based in India and Japan. Kritika Nayak's co-authors include Manju Misra, Rakesh Kumar Tekade, Deepak Pradhan, Vishakha Tambe, Kiran Kalia, Rahul Maheshwari, Sameer S. Katiyar, Varun Kushwah, Sanyog Jain and Dignesh Khunt and has published in prestigious journals such as Journal of Controlled Release, Biomedicine & Pharmacotherapy and ACS Omega.

In The Last Decade

Kritika Nayak

8 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kritika Nayak India 7 206 135 91 86 78 8 357
Akshay R. Koli India 8 295 1.4× 234 1.7× 79 0.9× 48 0.6× 78 1.0× 11 464
Shin-ichi Yasueda Japan 9 112 0.5× 102 0.8× 48 0.5× 84 1.0× 69 0.9× 15 363
Yanzhong Chen China 14 321 1.6× 215 1.6× 81 0.9× 128 1.5× 87 1.1× 28 587
Zhufen Lu China 13 257 1.2× 137 1.0× 46 0.5× 80 0.9× 33 0.4× 16 419
Marina Juretić Croatia 9 212 1.0× 124 0.9× 48 0.5× 40 0.5× 28 0.4× 10 367
Joel G. Souza Brazil 8 144 0.7× 70 0.5× 42 0.5× 89 1.0× 24 0.3× 11 348
Vincent Baeyens Switzerland 9 167 0.8× 233 1.7× 121 1.3× 43 0.5× 120 1.5× 11 404
Ola Camber Sweden 15 294 1.4× 185 1.4× 67 0.7× 132 1.5× 88 1.1× 22 572
S Keipert Germany 11 251 1.2× 150 1.1× 67 0.7× 79 0.9× 55 0.7× 25 422
Nurşen Ünlü Türkiye 14 319 1.5× 232 1.7× 152 1.7× 145 1.7× 125 1.6× 16 625

Countries citing papers authored by Kritika Nayak

Since Specialization
Citations

This map shows the geographic impact of Kritika Nayak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kritika Nayak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kritika Nayak more than expected).

Fields of papers citing papers by Kritika Nayak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kritika Nayak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kritika Nayak. The network helps show where Kritika Nayak may publish in the future.

Co-authorship network of co-authors of Kritika Nayak

This figure shows the co-authorship network connecting the top 25 collaborators of Kritika Nayak. A scholar is included among the top collaborators of Kritika Nayak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kritika Nayak. Kritika Nayak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Nayak, Kritika, et al.. (2022). Role of mucoadhesive agent in ocular delivery of ganciclovir microemulsion: cytotoxicity evaluation in vitro and ex vivo. International Ophthalmology. 43(4). 1153–1167. 5 indexed citations
2.
Nayak, Kritika & Manju Misra. (2020). PEGylated microemulsion for dexamethasone delivery to posterior segment of eye. Journal of Biomaterials Science Polymer Edition. 31(8). 1071–1090. 12 indexed citations
3.
Nayak, Kritika & Manju Misra. (2020). Triamcinolone Acetonide-Loaded PEGylated Microemulsion for the Posterior Segment of Eye. ACS Omega. 5(14). 7928–7939. 17 indexed citations
4.
Nayak, Kritika, et al.. (2019). Exploring the potential of minoxidil tretinoin liposomal based hydrogel for topical delivery in the treatment of androgenic alopecia. Cutaneous and Ocular Toxicology. 39(1). 43–53. 28 indexed citations
5.
Nayak, Kritika, et al.. (2019). Cow ghee fortified ocular topical microemulsion; in vitro, ex vivo, and in vivo evaluation. Journal of Microencapsulation. 36(7). 603–621. 19 indexed citations
6.
Nayak, Kritika & Manju Misra. (2018). A review on recent drug delivery systems for posterior segment of eye. Biomedicine & Pharmacotherapy. 107. 1564–1582. 172 indexed citations
7.
Nayak, Kritika, Sameer S. Katiyar, Varun Kushwah, & Sanyog Jain. (2017). Coenzyme Q10 and retinaldehyde co-loaded nanostructured lipid carriers for efficacy evaluation in wrinkles. Journal of drug targeting. 26(4). 333–344. 27 indexed citations
8.
Tambe, Vishakha, Deepak Pradhan, Kritika Nayak, et al.. (2017). Novel nanosystems for the treatment of ocular inflammation: Current paradigms and future research directions. Journal of Controlled Release. 268. 19–39. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026